COMMUNIQUÉS West-GlobeNewswire

Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update

14/03/2018 - 22:29

14-day Study of PTI-801, Company’s Third Generation Corrector, in CF Patients on Background Orkambi ® Enrolling Ahead of Schedule; Results from All Three Cohorts Expected Q2'18 Company Announces Additional Study of PTI- [...]

Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting

14/03/2018 - 22:00

CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today presented promising clinical data from [...]

NewLink Genetics Announces Presentation of Abstracts at AACR Annual Meeting

14/03/2018 - 22:00

AMES, Iowa, March 14, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported that two abstracts pertaining to the company's indoximod program will be presented at the American Association [...]

TESARO Announces Data Presentations at the 2018 American Association for Cancer Research Annual Meeting

14/03/2018 - 21:50

WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced that data for ZEJULA, TSR-042 (anti-PD-1 antibody) and the company’s immuno [...]

Solid Biosciences Announces Clinical Hold On SGT-001 Phase I/II Clinical Trial For Duchenne Muscular Dystrophy

14/03/2018 - 21:46

CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) today announced it has received notification from the U.S. Food and Drug Administration (FDA) that IGNITE DMD, its Phase I/II [...]

Aduro Biotech Announces Upcoming Data Presentations at the 2018 American Association for Cancer Research Annual Meeting

14/03/2018 - 21:31

BERKELEY, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), today announced three preclinical data presentations highlighting its STING and antibody product candidates will be delivered at [...]

Proteostasis Therapeutics Announces FDA Grants Orphan Drug Designation for PTI-428 in Cystic Fibrosis

14/03/2018 - 21:30

CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]

The Ensign Group to Present at the Oppenheimer 28th Annual Healthcare Conference

14/03/2018 - 21:30

MISSION VIEJO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]

Precision Therapeutics Increases Equity Stake in Helomics to 25%

14/03/2018 - 21:30

MINNEAPOLIS, March 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized [...]

Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update

14/03/2018 - 21:13

--Firdapse ® NDA to be Resubmitted Before the End of this Quarter --Significant Progress with MuSK-MG Regulatory and Clinical Program --$84M Year-End Cash and Investments --Company to Host Quarterly Conference Call at 5 [...]

Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results

14/03/2018 - 21:08

RSV Phase 3 Prepare™ Trial Outcome De-risked by Successful Informational Analysis NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine John J. Trizzino Appointed Chief [...]

Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results

14/03/2018 - 21:05

PLYMOUTH MEETING, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today reported financial results for the fourth quarter and year ended December 31, 2017. Total revenue was $8.8 [...]

Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer

14/03/2018 - 21:05

GAITHERSBURG, Md., March 14, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced the promotion of John J. Trizzino to Senior Vice President, Chief Business Officer (CBO) and Chief Financial Officer ( [...]

miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

14/03/2018 - 21:05

Data from Phase 1 clinical trial supports advancing cobomarsen, or MRG-106, into a Phase 2 potentially registrational clinical trial for CTCL (the SOLAR trial) Completed Phase 1 clinical trial of MRG-201 supports [...]

Sunesis Pharmaceuticals to Present at Upcoming Investor Conferences

14/03/2018 - 21:05

SOUTH SAN FRANCISCO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that the Company will present at two upcoming investor conferences. Willie Quinn, Chief [...]

Carrie Arran Resources Announces Proposed Private Placement With Insider Participation

14/03/2018 - 21:05

TORONTO, March 14, 2018 (GLOBE NEWSWIRE) -- Carrie Arran Resources Inc. (the “ Corporation ”) is pleased to announce a proposed non-brokered private placement (the “ Private Placement ”) of up to 600,000 common shares [...]

Invuity Announces Proposed Public Offering of Common Stock

14/03/2018 - 21:04

SAN FRANCISCO, March 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ) ("Invuity" or the "Company"), a leading medical technology company focused on minimal access surgery, today announced that it intends to [...]

Aduro Biotech to Present at the 28th Annual Oppenheimer Healthcare Conference

14/03/2018 - 21:01

BERKELEY, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 28th Annual [...]

Trevena to Present at the Oppenheimer & Company 28th Annual Healthcare Conference

14/03/2018 - 21:01

CHESTERBROOK, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Oppenheimer & Company 28th Annual Healthcare Conference on Wednesday, March 21, [...]